Perspectives and insights regarding regulatory considerations when planning and conducting immunotherapy studies.
Anna Baran, MD
Advertisement
Articles by Anna Baran, MD
IMPs for immunotherapeutics require a different mindset, effective strategies, and meticulous planning, among other things, says KCR Trial Execution and Consulting.
Advertisement
Latest Updated Articles
Initial Design Considerations of Trials of Immuno-Oncology: Domains and ElementsPublished: June 4th 2020 | Updated:
- Initial Design Considerations for Immuno-Oncology Trials
Published: August 13th 2020 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
